Pharmaceutical formulations of highly lipophilic camptothecin derivatives
US5935967A · kind A · utility
11Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 1998 |
| Grant date | Aug 10, 1999 |
| Priority date | — |
| Expiry date | Jan 20, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical formulations of highly lipophilic, poorly water soluble derivatives of Camptothecin are disclosed. The formulations include an effective amount of the HLCD dissolved or suspended in an appropriate amount of N-methyl-2-pyrrolidinone (NMP), and one or more pharmaceutically acceptable excipients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.